- Home
- AAPG vs HTFL Comparison
AAPG vs HTFL Comparison
Compare AAPG & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAPG | HTFL |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AAPG | HTFL |
|---|---|---|
| Price | $23.88 | $22.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $48.50 | $39.20 |
| AVG Volume (30 Days) | 1.7K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $368.64 | $22.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.56 | $20.13 |
| 52 Week High | $48.45 | $41.22 |
Technical Indicators
Market Signals| Indicator | AAPG | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 39.16 |
| Support Level | $23.06 | $20.13 |
| Resistance Level | $26.01 | $32.52 |
| Average True Range (ATR) | 0.93 | 1.54 |
| MACD | 0.13 | 0.14 |
| Stochastic Oscillator | 62.79 | 23.61 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.